Eritrea vs Canada vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 93% | 92% |
| 2023 | 93% | 92% |
| 2022 | 93% | 92% |
| 2021 | 93% | 90% |
| 2020 | 93% | 90% |
| 2019 | 93% | 90% |
| 2018 | 93% | 90% |
| 2017 | 93% | 90% |
| 2016 | 95% | 89% |
| 2015 | 97% | 89% |
| 2014 | 90% | 90% |
| 2013 | 94% | 90% |
| 2012 | 98% | 89% |
| 2011 | 96% | 88% |
| 2010 | 95% | 90% |
| 2009 | 93% | 91% |
| 2008 | 91% | 93% |
| 2007 | 92% | 94% |
| 2006 | 94% | 93% |
| 2005 | 95% | 94% |
| 2004 | 96% | 94% |
| 2003 | 92% | 95% |
| 2002 | 83% | 95% |
| 2001 | 84% | 95% |
| 2000 | 76% | 96% |
| 1999 | 88% | 96% |
| 1998 | 79% | 96% |
| 1997 | 73% | 96% |
| 1996 | 66% | 97% |
| 1995 | 58% | 96% |
| 1994 | 51% | 97% |
| 1993 | 34% | 96% |
| 1992 | - | 94% |
| 1991 | - | 92% |
| 1990 | - | 89% |
| 1989 | - | 87% |
| 1988 | - | 85% |
| 1987 | - | 70% |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 95% | 92% |
| 2023 | 95% | 92% |
| 2022 | 95% | 92% |
| 2021 | 95% | 92% |
| 2020 | 95% | 92% |
| 2019 | 95% | 91% |
| 2018 | 95% | 91% |
| 2017 | 95% | 91% |
| 2016 | 95% | 91% |
| 2015 | 95% | 91% |
| 2014 | 94% | 91% |
| 2013 | 94% | 91% |
| 2012 | 94% | 91% |
| 2011 | 94% | 87% |
| 2010 | 95% | 89% |
| 2009 | 95% | 91% |
| 2008 | 95% | 92% |
| 2007 | 95% | 94% |
| 2006 | 94% | 95% |
| 2005 | 96% | 93% |
| 2004 | 98% | 91% |
| 2003 | 93% | 91% |
| 2002 | 90% | 88% |
| 2001 | 86% | 89% |
| 2000 | 81% | 89% |
| 1999 | 93% | 90% |
| 1998 | 86% | 90% |
| 1997 | 75% | 86% |
| 1996 | 66% | 90% |
| 1995 | 58% | 87% |
| 1994 | 49% | 93% |
| 1993 | 32% | 90% |
| 1992 | - | 89% |
| 1991 | - | 88% |
| 1990 | - | 88% |
| 1989 | - | 87% |
| 1988 | - | 86% |
| 1987 | - | 85% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 95% | 83% |
| 2023 | 95% | 83% |
| 2022 | 95% | 83% |
| 2021 | 95% | 84% |
| 2020 | 95% | 84% |
| 2019 | 95% | 84% |
| 2018 | 95% | 71% |
| 2017 | 95% | 71% |
| 2016 | 95% | 70% |
| 2015 | 95% | 69% |
| 2014 | 94% | 55% |
| 2013 | 94% | 55% |
| 2012 | 94% | 70% |
| 2011 | 94% | 70% |
| 2010 | 95% | 56% |
| 2009 | 95% | 42% |
| 2008 | 95% | 28% |
| 2007 | 95% | 14% |
| 2006 | 94% | 14% |
| 2005 | 96% | 14% |
| 2004 | 84% | 14% |
| 2003 | 91% | 14% |
| 2002 | 86% | - |
| 2001 | - | - |
| 2000 | - | - |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
| 1991 | - | - |
| 1990 | - | - |
| 1989 | - | - |
| 1988 | - | - |
| 1987 | - | - |
The first measles dose reaches 93% of children aged 12–23 months in Eritrea and 92% in Canada: 1 percentage point more in Eritrea. The third DTP dose reaches 95% in Eritrea and 92% in Canada, 3 points more in Eritrea. The third hepatitis B dose reaches 95% in Eritrea and 83% in Canada, 12 points more in Eritrea. In 1993, the first measles dose reached 34% in Eritrea and 96% in Canada, 62 percentage points more in Canada.
Eritrea vs Canada: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 93% (2024) | 92% (2024) |
| DTP3 | 95% (2024) | 92% (2024) |
| HepB3 | 95% (2024) | 83% (2024) |
Eritrea and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Canada and nearby countries: measles vaccination (MCV1), % of children aged 12–23 months
Of Eritrea and its three neighbors, the latest coverage of the first measles dose is highest in Eritrea, at 93%, and lowest in Sudan, at 46%; of Canada and the five nearby countries, the latest coverage of the first measles dose is highest in Cuba, at 99%, and lowest in Mexico, at 80%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1987–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.